LIM kinase/cofilin dysregulation promotes macrothrombocytopenia in severe von Willebrand disease-type 2B

Autor: Valérie Proulle, Audrey Pietrzyk-Nivau, Frédéric Adam, Sonia Poirault-Chassac, Cécile V. Denis, Christelle Soukaseum, Peter J. Lenting, Jean-Philippe Rosa, Jean-Claude Bordet, Vincent Muczynski, Gabriel Aymé, Chantal Rothschild, Dominique Baruch, Eliane Berrou, Marijke Bryckaert, Olivier D. Christophe, Caterina Casari, Alexandre Kauskot
Přispěvatelé: Institut National de la Santé et de la Recherche Médicale (INSERM), AYME, Gabriel
Jazyk: angličtina
Rok vydání: 2016
Předmět:
Male
rho GTP-Binding Proteins
0301 basic medicine
MESH: Signal Transduction
RHOA
[SDV.BIO]Life Sciences [q-bio]/Biotechnology
[SDV.BBM.BM] Life Sciences [q-bio]/Biochemistry
Molecular Biology/Molecular biology

Platelet membrane glycoprotein
Mice
0302 clinical medicine
hemic and lymphatic diseases
Platelet
MESH: Animals
Gene Knock-In Techniques
MESH: von Willebrand Factor
[SDV.BBM.BC] Life Sciences [q-bio]/Biochemistry
Molecular Biology/Biochemistry [q-bio.BM]

MESH: Gene Knock-In Techniques
biology
Lim Kinases
General Medicine
Cofilin
Cell biology
[SDV.BBM.BC]Life Sciences [q-bio]/Biochemistry
Molecular Biology/Biomolecules [q-bio.BM]

MESH: von Willebrand Disease
Type 2

Actin Depolymerizing Factors
[SDV.SP.PHARMA] Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
[SDV.IMM]Life Sciences [q-bio]/Immunology
[SDV.IMM.IMM] Life Sciences [q-bio]/Immunology/Immunotherapy
Research Article
Signal Transduction
MESH: rhoA GTP-Binding Protein
[SDV.SP.MED] Life Sciences [q-bio]/Pharmaceutical sciences/Medication
MESH: Mutation
[SDV.IMM] Life Sciences [q-bio]/Immunology
von Willebrand Disease
Type 2

macromolecular substances
[SDV.SP.PG] Life Sciences [q-bio]/Pharmaceutical sciences/Galenic pharmacology
Lim kinase
03 medical and health sciences
Von Willebrand factor
[SDV.SP.MED]Life Sciences [q-bio]/Pharmaceutical sciences/Medication
von Willebrand Factor
MESH: Actin Depolymerizing Factors
Von Willebrand disease
medicine
Animals
Humans
MESH: Mice
Actin
MESH: Thrombocytopenia
MESH: Humans
[SDV.BBM.BM]Life Sciences [q-bio]/Biochemistry
Molecular Biology/Molecular biology

[SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy
medicine.disease
MESH: rho GTP-Binding Proteins
Thrombocytopenia
MESH: Lim Kinases
MESH: Male
[SDV.BIO] Life Sciences [q-bio]/Biotechnology
030104 developmental biology
[SDV.SP.PG]Life Sciences [q-bio]/Pharmaceutical sciences/Galenic pharmacology
Mutation
Immunology
biology.protein
[SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
rhoA GTP-Binding Protein
030215 immunology
Zdroj: JCI Insight
JCI Insight, American Society for Clinical Investigation, 2016, 1 (16), pp.e88643. ⟨10.1172/jci.insight.88643⟩
ISSN: 2379-3708
Popis: International audience; von Willebrand disease type 2B (VWD-type 2B) is characterized by gain-of-function mutations of von Willebrand factor (vWF) that enhance its binding to platelet glycoprotein Ibα and alter the protein's multimeric structure. Patients with VWD-type 2B display variable extents of bleeding associated with macrothrombocytopenia and sometimes with thrombopathy. Here, we addressed the molecular mechanism underlying the severe macrothrombocytopenia both in a knockin murine model for VWD-type 2B by introducing the p.V1316M mutation in the murine Vwf gene and in a patient bearing this mutation. We provide evidence of a profound defect in megakaryocyte (MK) function since: (a) the extent of proplatelet formation was drastically decreased in 2B MKs, with thick proplatelet extensions and large swellings; and (b) 2B MKs presented actin disorganization that was controlled by upregulation of the RhoA/LIM kinase (LIMK)/cofilin pathway. In vitro and in vivo inhibition of the LIMK/cofilin signaling pathway rescued actin turnover and restored normal proplatelet formation, platelet count, and platelet size. These data indicate, to our knowledge for the first time, that the severe macrothrombocytopenia in VWD-type 2B p.V1316M is due to an MK dysfunction that originates from a constitutive activation of the RhoA/LIMK/cofilin pathway and actin disorganization. This suggests a potentially new function of vWF during platelet formation that involves regulation of actin dynamics.
Databáze: OpenAIRE